These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17718292)

  • 21. [Effect of a risk of malignancy index in preoperative diagnosis of ovarian cancer].
    Ma S; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Mar; 36(3):162-4. PubMed ID: 11783394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of malignancy index (RMI) in women with adnexal masses in Wales.
    Abdulrahman GO; McKnight L; Lutchman Singh K
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):376-81. PubMed ID: 25286794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparisons of Effectiveness in Differentiating Benign from Malignant Ovarian Masses between Conventional and Modified Risk of Malignancy Index (RMI).
    Tantipalakorn C; Tinnangwattana D; Lerthiranwong T; Luewan S; Tongsong T
    Int J Environ Res Public Health; 2023 Jan; 20(1):. PubMed ID: 36613208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Value of Malignancy Risk Indices for Ovarian Masses in Premenopausal and Postmenopausal Women.
    Ertas S; Vural F; Vural F; Tufekci EC; Ertas AC; Kose G; Aka N
    Asian Pac J Cancer Prev; 2016; 17(4):2177-83. PubMed ID: 27221915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses.
    Timmerman D; Verrelst H; Bourne TH; De Moor B; Collins WP; Vergote I; Vandewalle J
    Ultrasound Obstet Gynecol; 1999 Jan; 13(1):17-25. PubMed ID: 10201082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ovarian tumor markers of presumed benign ovarian tumors].
    Lahlou N; Brun JL
    J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):752-9. PubMed ID: 24210243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
    Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
    Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive values of the ultrasound parameters, CA-125 and risk of malignancy index in patients with ovarian cancer.
    Antovska SV; Bashevska N; Aleksioska N
    Klin Onkol; 2011; 24(6):435-42. PubMed ID: 22257232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound Features Improve Diagnostic Performance of Ovarian Cancer Predictors in Distinguishing Benign and Malignant Ovarian Tumors.
    Chen YN; Ma F; Zhang YD; Chen L; Li CY; Gong SP
    Curr Med Sci; 2020 Feb; 40(1):184-191. PubMed ID: 32166682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of a risk of malignancy index in clinical approaches to adnexal masses.
    Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T
    Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases?
    Bailey J; Tailor A; Naik R; Lopes A; Godfrey K; Hatem HM; Monaghan J
    Int J Gynecol Cancer; 2006; 16 Suppl 1():30-4. PubMed ID: 16515564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
    Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
    Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population.
    Ong C; Biswas A; Choolani M; Low JJ
    Singapore Med J; 2013 Mar; 54(3):136-9. PubMed ID: 23546025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
    Karlsen MA; Høgdall EV; Christensen IJ; Borgfeldt C; Kalapotharakos G; Zdrazilova-Dubska L; Chovanec J; Lok CA; Stiekema A; Mutz-Dehbalaie I; Rosenthal AN; Moore EK; Schodin BA; Sumpaico WW; Sundfeldt K; Kristjansdottir B; Zapardiel I; Høgdall CK
    Gynecol Oncol; 2015 Sep; 138(3):640-6. PubMed ID: 26086566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of malignancy index in the preoperative evaluation of pelvic masses.
    Obeidat BR; Amarin ZO; Latimer JA; Crawford RA
    Int J Gynaecol Obstet; 2004 Jun; 85(3):255-8. PubMed ID: 15145261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
    Antonić J; Rakar S
    Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
    Sagi-Dain L; Lavie O; Auslander R; Sagi S
    Int J Biol Markers; 2015 Jul; 30(3):e333-40. PubMed ID: 25704505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.